-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L3p3k4Bg2meCazt6IPinhNz6IyL4KFk4Xiyu/g1CMkfwyien09B7lGTe2Rcazv5c ylE6oGBFdSJx14ILIuoqVg== 0001079974-06-000112.txt : 20060320 0001079974-06-000112.hdr.sgml : 20060320 20060320130422 ACCESSION NUMBER: 0001079974-06-000112 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20060315 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20060320 DATE AS OF CHANGE: 20060320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC CENTRAL INDEX KEY: 0000846475 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 870403828 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 033-26787-D FILM NUMBER: 06698070 BUSINESS ADDRESS: STREET 1: 8100 SOUTH PARK WAY STREET 2: SUITE A-9 CITY: LITTLETON STATE: CO ZIP: 80120 BUSINESS PHONE: (303) 703-4906 MAIL ADDRESS: STREET 1: 8100 SOUTH PARK WAY STREET 2: SUITE A-9 CITY: LITTLETON STATE: CO ZIP: 80120 FORMER COMPANY: FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC DATE OF NAME CHANGE: 20040120 FORMER COMPANY: FORMER CONFORMED NAME: FOX RIVER HOLDINGS INC DATE OF NAME CHANGE: 20031126 FORMER COMPANY: FORMER CONFORMED NAME: ARIZONA VENTURES INC DATE OF NAME CHANGE: 20030115 8-K 1 zynex8k_3202006.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2006 --------------- Zynex Medical Holdings, Inc. ------------------------------------------------------ (Exact name of Registrant as specified in its charter) Nevada 33-26787-D 90-0214497 ------------------ -------------- --------------------- (State or other (Commission (I.R.S. Employer jurisdiction File Number) Identification No.) of incorporation) 8100 South Park Way, Suite A-9, Littleton, CO 80120 --------------------------------------------- ---------- (Address of principal executive offices) (Zip Code) Registrant's telephone number: (303) 703-4906 -------------- Total pages: 3 --- Exhibit index at: 2 --- Item 1.01 Entry into a Material Definitive Agreement Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant On March 15, 2006 Zynex Medical Holdings, Inc. and Zynex Medical, Inc (collectively "Zynex") received a loan of $240,000 under a Default Waiver and First Amendment To Loan and Security Agreement with Silicon Valley Bank dated September 29, 2005. The Amendment to the existing loan agreement of September 29, 2005 provided for this second term loan and waived one covenant for the time period ended December 31, 2005. The new loan bears interest at a per annum fixed rate of 8.48%. Registrant will repay the loan in 36 equal monthly payments of principal and interest, beginning April 1, 2006. All other terms and conditions are as stated in the September 29, 2005 loan agreement. The new loan is guaranteed by Zynex Chairman, President, Chief Executive Officer and major shareholder Thomas Sandgaard and is collateralized by a first security interest in accounts, inventory, chattel paper, equipment, fixtures, general intangibles, including intellectual property and other assets. Item 9.01 Finanical Statements and Exhibits The following exhibits are filed with this Report: Exhibit No. Document ----------- --------------------------------------------- 10.1 Default Waiver and First Amendment to Loan and Securiy Agreement, March 6, 2005 10.2 Unconditional Guaranty by Thomas Sandgaard for Silicon Valley Bank, dated March 6, 2005. 99.1 Press Release dated March 17, 2006. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Zynex Medical Holdings, Inc. (Registrant) Date: March 20, 2006 By: /s/ Thomas Sandgaard ------------------------------------- Thomas Sandgaard President and Chief Executive Officer EXHIBIT INDEX Exhibit No. Document ----------- ------------------------------------------------------ 10.1 Default Waiver and First Amendment to Loan and Security Agreement, March 6, 2005 10.2 Unconditional Guaranty by Thomas Sandgaard for Silicon Valley Bank, dated March 6, 2006 99.1 Press Release dated March 17, 2006 EX-10.1 2 zynex8kex101_3202006.txt Exhibit 10.1 DEFAULT WAIVER AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT This DEFAULT WAIVER AND FIRST AMENDMENT to Loan and Security Agreement (this "Amendment") is entered into this 6dt day of March, 2006, by and among Silicon Valley Bank \Bank} and Zynex Medical Holdings, Inc., a Nevada corporation, and Zynex Medical, Inc., a Colorado corporation (jointly and severally, "Borrower") whose address is 8100 Southpark Way, Suite A-9, Littleton, Colorado 80120. RECITALS A. Bank and Borrower have entered into that certain Loan and Security Agreement dated as of September 29, 2005 (as the same may from time to time be amended, modified, supplemented or restated, the "Loan Agreement"). Bank has extended credit to Borrower for the purposes permitted in the Loan Agreement. B. Borrower is currently in default of the Loan Agreement for failing to comply with the Debt Service Coverage covenant set forth in Section 6.7(i) of the Loan Agreement for the period ended December 31, 2005 (the "Existing Default"). C. Borrower has requested that Bank waive its rights and remedies against Borrower, limited specifically to the Existing Default. Although Bank is under no obligation to do so, Bank is willing to not exercise its rights and remedies against Borrower related to the specific Existing Default on the terms and conditions set forth in this Amendment, so long as Borrower complies with the terms, covenants and conditions set forth in this Amendment. D. Borrower bas further requested that Bank amend the Loan Agreement to make an additional term loan available to Borrower Bank has agreed to so amend certain provisions of the Loan Agreement, but only to the extent, in accordance with the terms, subject to the conditions and in reliance upon the representations and warranties set forth below. AGREEMENT Now, THEREFORE, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows: 1. Definitions. Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Loan Agreement. 2. Waiver of Covenant Default. Bank hereby waives Borrower s Existing Default. Bank's waiver of Borrower 's compliance of this covenant shall apply only to the foregoing period. Accordingly, as of period ended January 31, 2006, Borrower shall be in compliance with this covenant, as amended herein. Bank's agreement to waive the above-described default (l) in no way shall be deemed an agreement by the Bank to waive Borrower's compliance with the above-described covenant as of all other dates and (2) shall not limit or impair the Bank's right to demand strict performance of this covenant as of all other dates and (3) shall not limit or impair the Bank's right to demand strict performance of all other covenants as of any date. 3. Amendments to Loan Agreement. 3.1 Section 2.1.2 (Term Loan 2). The following Section 2.1.2 is hereby incorporated into the Loan Agreement: 3. Bank will make a Term Loan 2 available to Borrower to be advanced on or prior to March 15, 2006. Borrower will pay 36 equal installments of principal and interest (the "Term Loan 2 Payment"). Each Term Loan 2 Payment is payable on the 1st of each month, beginning April, 1,2006, during the term of the loan. Borrower's final Term Loan 2 Payment, due on March 1,2009, includes all outstanding Term Loan 2 principal and accrued interest. Bank's obligation to lend the undisbursed portion of the Obligations will terminate it: in Bank's sole discretion, there has been a material adverse change in the general affairs, management, results of operation, condition (financial or otherwise) or the prospect of repayment of the Obligations, or there has been any material adverse deviation by Borrower from the most recent business plan of Borrower presented to and accepted by Bank prior to the execution of this Agreement. 3.2 Section 2.2 (Interest Rate, Payments). The first sentence in paragraph "(a)" of Section 2.2 is hereby amended to read as follows: The Term Loan accrues interest at a per annum rate equal to the Basic Rate and the Term Loan 2 accrues interest at a per annum rate equal to the Basic 2 Rate. 3.3 Section 13 (Definitions). The following terms and their respective definitions are hereby incorporated into Section 13.1: "Basic 2 Rate" is, as of the date in which the Term Loan 2 is advanced, the per annum rate of interest equal to the sum of (a) the U.S. Treasury note yield to maturity for a term of36 months as quoted in The Wall Street Journal on such date, plus (b) 375 basis points. "Term Loan 2" is a Loan of up to $240,000. "Term Loan 2 Maturity Date" is March 1,2009. 4. Limitation of Amendments. 4.1 The amendments set forth in Section 3, above, are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right or remedy which Bank may now have or may have in the future under or in connection with any Loan Document. 4.2 This Amendment shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the Loan Documents, except as herein amended, are hereby ratified and confirmed and shall remain in full force and effect. 5. Representations and Warranties. To induce Bank to enter into this Amendment, Borrower hereby represents and warrants to Bank as follows: 5.1 Immediately after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default other than the Existing Default has occurred and is continuing; 5.2 Borrower has the power and authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement, as amended by this Amendment; . 5.3 The organizational documents of Borrower delivered to Bank on the Effective Date remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect; 5.4 The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, have been duly authorized by all necessary action on the part of Borrower; 5.5 The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not and will not contravene (a) any law or regulation binding on or affecting Borrower, (b) any contractual restriction with a Person binding on Borrower, (c) any order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof, binding on Borrower, or (d) the organizational documents of Borrower; . 5.6 The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not require any order, consent, approval, license, authorization or validation of, or filing. recording or registration with, or exemption by any governmental or public body or authority. or subdivision thereof, binding on either Borrower. except as already has been obtained or made; and 5.7 This Amendment has been duly executed and delivered by Borrower and is the binding obligation of Borrower. enforceable against Borrower in accordance with its terms. except as such enforceability may be limited by bankruptcy. insolvency. reorganization. liquidation. moratorium or other similar laws of general application and equitable principles relating to or affecting creditors' rights. 6. Prior Agreement. Except as expressly provided for in this Amendment, the Loan Documents are hereby ratified and reaffirmed and shall remain in full force and effect. This Amendment is not a novation and the terms and conditions of this Amendment shall be in addition to and supplemental to all terms and conditions set forth in the Loan Documents. In the event of any conflict or inconsistency between this Amendment and the terms of such documents. the terms of this Amendment shall be controlling. but such document shall not otherwise be affected or the rights therein impaired. 7. Release by Borrower. 7.1 FOR GOOD AND VALUABLE CONSIDERATION. Borrower hereby forever relieves. releases. and discharges Bank and its present or former employees. officers. directors, agents. representatives, attorneys. and each of them. from any and all claims. debts. liabilities. demands, obligations. promises. acts. agreements. costs and expenses. actions and causes of action, of every type. kind, nature, description or character whatsoever. whether known or unknown. suspected or unsuspected, absolute or contingent, arising out of or in any manner whatsoever connected with or related to facts. circumstances. issues. controversies or claims existing or arising nom the beginning of time through and including the date of execution of this Amendment (collectively "Released Claims"). Without limiting the foregoing. the Released Claims shall include any and all liabilities or claims arising out of or in any manner whatsoever connected with or related to the Loan Documents. the Recitals hereto. any instruments. agreements or documents executed in connection with any of the foregoing or the origination, negotiation, administration. servicing and/or enforcement of any of the foregoing. 7.2 Intentionally Omitted. 7.3 By entering into this release. Borrower recognizes that no facts or representations are ever absolutely certain and it may hereafter discover facts in addition to or different from those which it presently knows or believes to be true. but that it is the intention of Borrower hereby to fully. finally and forever settle and release all matters. disputes and differences, known or unknown, suspected or unsuspected; accordingly. if Borrower should subsequently discover that any fact that it relied upon in entering into this release was untrue. or that any understanding of the facts was incorrect, Borrower shall not be entitled to set aside this release by reason thereof. regardless of any claim of mistake of fact or law or any other circumstances whatsoever. Borrower acknowledges that it is not relying upon and has not relied upon any representation or statement made by Bank with respect to the facts underlying this release or with regard to any of such party's rights or asserted rights. 7.4 This release may be pleaded as a full and complete defense and/or as a cross-complaint or counterclaim against any action, suit, or other proceeding that may be instituted, prosecuted or attempted in breach of this release. Borrower acknowledges that the release contained herein constitutes a material inducement to Bank to enter into this Amendment, and that Bank would not have done so but for Bank's expectation that such release is valid and enforceable in all events. 7.5 Borrower hereby represents and warrants to Bank, and Bank is relying thereon, as follows: (a) Except as expressly stated in this Amendment, neither Bank nor any agent, employee or representative of Bank has made any statement or representation to Borrower regarding any fact relied upon by Borrower in entering into this Amendment. (b) Borrower has made such investigation of the facts pertaining to this Amendment and all of the matters appertaining thereto, as it deems necessary . (c) The terms of this Amendment are contractual and not a mere recital. (d) This Amendment has been carefully read by Borrower, the contents hereof are known and understood by Borrower, and this Amendment is signed freely, and without duress, by Borrower. (e) Borrower represents and warrants that it is the sole and lawful owner of all right, title and interest in and to every claim and every other matter which it releases herein, and that it has not heretofore assigned or transferred, or purported to assign or transfer, to any person, firm or entity any claims or other matters herein released. Borrower shall indemnify Bank, defend and hold it harmless from and against all claims based upon or arising in connection with prior assignments or purported assignments or transfers of any claims or matters released herein. 8. Counterparts. This Amendment may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to constitute one and the same instrument. 9. Effectiveness. This Amendment shall be deemed effective upon (a) the due execution and delivery to Bank of this Amendment by each party hereto, (b) Borrower's payment of an amendment fee in an amount equal to $2,500, and (c) Bank's receipt of the Acknowledgment of Amendment and Reaffirmation of Guaranty substantially in the form attached hereto as Schedule I, duly executed and delivered by each Guarantor. 10. Governing Law. This Amendment and the rights and obligations of the parties hereto shall be governed by and construed in accordance with the laws of the State of Colorado. IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered as of the date first written above. BANK BORROWER Silicon Valley Bank Zynex Medical, Inc. By: By: Name: Name: Title: Title: Zynex Medical Holdings, Inc. By: Name: Title: EX-10.2 3 zynex8kex102_3202006.txt Exhibit 10.2 ACKNOWLEDGMENT OF AMENDMENT AND REAFFIRMATION OF GUARANTY Section 1. Guarantor hereby acknowledges and confirms that it has reviewed and approved the terms and conditions of the Default Waiver. and First Amendment to Loan and Security Agreement dated as of even date herewith (the "Amendment"). Section 2. Guarantor hereby consents to the Amendment and agrees that the Guaranty relating to the Obligations of Borrower under the Loan Agreement shall continue in full force and effect, shall be valid and enforceable and shall not be impaired or otherwise affected by the execution of the Amendment or any other document or instrument delivered in connection herewith. Section 3. Guarantor represents and warrants that, after giving effect to the Amendment. all representations and warranties contained in the Guaranty are true. accurate and complete as if made the date hereof. Dated as of March 6, 2006 GUARANTOR /s/ Thomas Sandgaard ------------------------- Thomas Sandgaard EX-99.1 4 zynex8kex991_3202006.txt Exhibit 99.1 FOR IMMEDIATE RELEASE: - ---------------------- ZYNEX RECEIVES INCREASE IN CREDIT FACILITY TO FINANCE GROWTH LITTLETON, Colo., March 17, 2006 - Zynex Medical Holdings, Inc. (OTCBB: ZYNX), a provider of pain management systems and electrotherapy products for medical patients with functional disability, today announced that Silicon Valley Bank, the primary operating subsidiary of SVB Financial Group (NASDAQ: SIVB), has increased the Company's credit facility by $240,000 to $600,000. The Company will use the additional funds for working capital. "The availability of an additional $240,000 in funding will enable Zynex to further ramp up our sales, marketing and support efforts in Europe and domestically for our NeuroMove(TM) Stroke Recovery System and related products," stated Zynex President and Chief Executive Officer Thomas Sandgaard. The NeuroMove(TM) system increases the functionality of many stroke victims by teaching the healthy parts of the brain to compensate for damaged areas. The NeuroMove(TM), which is significantly more sensitive than most diagnostic equipment, monitors muscle activity and selects signals from the brain indicating that the patient is attempting to move a certain muscle. It then introduces the actual movement through electrical stimulation. Eventually the connection between the brain and muscle can often be reestablished. The NeuroMove(TM) (www.neuromove.com) also can be used to treat spinal cord injuries. About Zynex Zynex Medical Holdings, Inc., (www.zynexmed.com), a leading provider of therapeutic devices for patients with functional disability through the creation, distribution, and marketing of electrotherapy devices since 1996, strives to uphold its mission to improve the quality of life of patients suffering from debilitating pain or illness by providing innovative technology. Utilizing a unique combination of electromyographic (EMG) technology combined with a system of instruction and reinforcement, including electrical muscle stimulation (EMS), Zynex offers new treatment options to post-stroke and spinal injury patients. About Silicon Valley Bank Silicon Valley Bank provides diversified financial services to emerging growth and mature companies in the technology, life science, private equity and premium wine industries. Through its focus on specialized markets and extensive knowledge of the people and business issues driving them, Silicon Valley Bank provides a level of service and partnership that measurably impacts its clients' success. Founded in 1983 and headquartered in Santa Clara, Calif., the company serves more than 10,000 clients around the world through 27 domestic offices and two international subsidiaries in the U.K. and India, and an extensive network of relationships with venture capitalists around the world. More information on the company can be found at www.svb.com. Thomas Sandgaard President and Chief Executive Officer 303-703-4906 or Ron Stabiner The Wall Street Group, Inc. 212-888-4848 2 Safe Harbor Provision Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the Company's ability to meet terms and conditions required to obtain project financing, risks and delays associated with product development, risk of market acceptance of new products, technology or product obsolescence, competitive risks, reliance on development partners and additional capital needs. # # # -----END PRIVACY-ENHANCED MESSAGE-----